Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Short report

Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development

Authors: Jee Eun Rhee, Mi Yeong Shin, Choong Mo Kim, Hye Young Kee, Jae Keun Chung, Sang-Kee Min, Seong-Joon Kim, Dai-Ho Jang, Sung Soon Kim, Byeong-Sun Choi

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

We investigated the prevalence of human papillomavirus (HPV) infection and the distribution of high-risk HPV genotypes among 2,308 high-risk Korean women to predict how much the current prophylactic HPV vaccines might affect the prevention of cervical cancer in Korea. HPV DNA was detected in 939 women (40.7%) but only one-third of women were positive for HPV-16 and/or HPV-18, the genotypes used for developing the HPV vaccines. Thus, the development of area-specific HPV vaccines based on dominant HPV genotypes in our country is needed for preventing HPV infection and the development of premalignant lesions in the cervix of Korean women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55: 244-265.PubMedPubMedCentralCrossRef Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55: 244-265.PubMedPubMedCentralCrossRef
2.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-FPubMedCrossRef Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189: 12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-FPubMedCrossRef
3.
go back to reference Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK: Nationwide cancer incidence in Korea 1999-2001; First result using the national cancer incidence database. Cancer Res Treat 2005, 37: 325-331. 10.4143/crt.2005.37.6.325PubMedPubMedCentralCrossRef Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK: Nationwide cancer incidence in Korea 1999-2001; First result using the national cancer incidence database. Cancer Res Treat 2005, 37: 325-331. 10.4143/crt.2005.37.6.325PubMedPubMedCentralCrossRef
4.
go back to reference Munoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527. 10.1056/NEJMoa021641PubMedCrossRef Munoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518-527. 10.1056/NEJMoa021641PubMedCrossRef
5.
go back to reference Chan PK, Mak KH, Cheung JL, Tang NL, Chan DP, Lo KK, Cheng AF: Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J Med Virol 2002, 68: 273-277. 10.1002/jmv.10189PubMedCrossRef Chan PK, Mak KH, Cheung JL, Tang NL, Chan DP, Lo KK, Cheng AF: Genotype spectrum of cervical human papillomavirus infection among sexually transmitted disease clinic patients in Hong Kong. J Med Virol 2002, 68: 273-277. 10.1002/jmv.10189PubMedCrossRef
6.
go back to reference Pretet JL, Jacquard AC, Carcopino X, EDITH study group: Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer 2008, 122: 424-427. 10.1002/ijc.23093 Pretet JL, Jacquard AC, Carcopino X, EDITH study group: Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer 2008, 122: 424-427. 10.1002/ijc.23093
7.
go back to reference Bae JH, Lee SJ, Kim CH, Hur SY, Park YG, Lee WC, Kim YT, Ng TL, Bock HL, Park JS: Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008, 18: 788-794.PubMed Bae JH, Lee SJ, Kim CH, Hur SY, Park YG, Lee WC, Kim YT, Ng TL, Bock HL, Park JS: Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008, 18: 788-794.PubMed
8.
go back to reference Adult KA, Future II Study group: Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials. Lancet 2007, 369: 1861-1868. 10.1016/S0140-6736(07)60852-6CrossRef Adult KA, Future II Study group: Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomized clinical trials. Lancet 2007, 369: 1861-1868. 10.1016/S0140-6736(07)60852-6CrossRef
9.
go back to reference Paavonen J, Jenkins D, Bosch FX, HPV PATRICIA Study Group, et al.: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a Phase III double-blind, randomized controlled trial. Lancet 2007, 369: 2161-2170. 10.1016/S0140-6736(07)60946-5PubMedCrossRef Paavonen J, Jenkins D, Bosch FX, HPV PATRICIA Study Group, et al.: Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a Phase III double-blind, randomized controlled trial. Lancet 2007, 369: 2161-2170. 10.1016/S0140-6736(07)60946-5PubMedCrossRef
10.
go back to reference Cutts FT, Franceschi S, Goldie S, Castellsague X, De Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L: Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 2007, 85: 719-726. 10.2471/BLT.06.038414PubMedPubMedCentralCrossRef Cutts FT, Franceschi S, Goldie S, Castellsague X, De Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L: Human papillomavirus and HPV vaccines: a review. Bull World Health Organ 2007, 85: 719-726. 10.2471/BLT.06.038414PubMedPubMedCentralCrossRef
11.
go back to reference Miyashita M, Agdamag DM, Sasagawa T, Matsushita L, Salud LM, Salud CO, Saikawa K, Leano PS, Pagcaliwagan T, Acuna J, Ishizaki A, Kageyama S, Ichimura H: High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines. J Med Virol 2009, 81: 545-551. 10.1002/jmv.21416PubMedCrossRef Miyashita M, Agdamag DM, Sasagawa T, Matsushita L, Salud LM, Salud CO, Saikawa K, Leano PS, Pagcaliwagan T, Acuna J, Ishizaki A, Kageyama S, Ichimura H: High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines. J Med Virol 2009, 81: 545-551. 10.1002/jmv.21416PubMedCrossRef
12.
go back to reference Del Amo J, Gonzalez C, Losana J, Clavo P, Munoz L, Ballesteros J, Garcia-Saiz A, Belza MJ, Ortiz M, Menendez B, Del Romero J, Bolumar F: Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 2005, 81: 79-84. 10.1136/sti.2003.008060PubMedPubMedCentralCrossRef Del Amo J, Gonzalez C, Losana J, Clavo P, Munoz L, Ballesteros J, Garcia-Saiz A, Belza MJ, Ortiz M, Menendez B, Del Romero J, Bolumar F: Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 2005, 81: 79-84. 10.1136/sti.2003.008060PubMedPubMedCentralCrossRef
13.
go back to reference Tideman RL, Thompson C, Rose B, Gilmour S, Marks C, Van Beek I, Berry G, O'Connor C, Mindel A: Cervical human papillomavirus infections in commercial sex workers - risk factors and behaviours . Int J STD AIDS 2003, 14: 840-847. 10.1258/095646203322556192PubMedCrossRef Tideman RL, Thompson C, Rose B, Gilmour S, Marks C, Van Beek I, Berry G, O'Connor C, Mindel A: Cervical human papillomavirus infections in commercial sex workers - risk factors and behaviours . Int J STD AIDS 2003, 14: 840-847. 10.1258/095646203322556192PubMedCrossRef
14.
go back to reference Ishi K, Suzuki F, Saito A, Kubota T: Prevalence of human papillomavirus, Chlamydia trachomatis and Neisseria gonorrhoeae in commercial sex workers in Japan . Infect Dis Obstet Gynecol 2000, 8: 235-239. 10.1002/1098-0997(2000)8:5<235::AID-IDOG1025>3.0.CO;2-UPubMedPubMedCentral Ishi K, Suzuki F, Saito A, Kubota T: Prevalence of human papillomavirus, Chlamydia trachomatis and Neisseria gonorrhoeae in commercial sex workers in Japan . Infect Dis Obstet Gynecol 2000, 8: 235-239. 10.1002/1098-0997(2000)8:5<235::AID-IDOG1025>3.0.CO;2-UPubMedPubMedCentral
15.
go back to reference Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS: Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J Med Virol 2003, 71: 440-445. 10.1002/jmv.10498PubMedCrossRef Choi BS, Kim O, Park MS, Kim KS, Jeong JK, Lee JS: Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J Med Virol 2003, 71: 440-445. 10.1002/jmv.10498PubMedCrossRef
16.
go back to reference Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, Kong HJ, Rha SH, Jung SI, Kim JI, Jung KY, Van Doorn LJ, Quint W: Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004, 190: 468-476. 10.1086/421279PubMedCrossRef Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, Kong HJ, Rha SH, Jung SI, Kim JI, Jung KY, Van Doorn LJ, Quint W: Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004, 190: 468-476. 10.1086/421279PubMedCrossRef
17.
go back to reference Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH: Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996, 23: 333-341. 10.1097/00007435-199607000-00013PubMedCrossRef Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH: Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996, 23: 333-341. 10.1097/00007435-199607000-00013PubMedCrossRef
18.
go back to reference Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, Van den Brule AJ: Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000, 27: 438-445. 10.1097/00007435-200009000-00003PubMedCrossRef Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, Van den Brule AJ: Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000, 27: 438-445. 10.1097/00007435-200009000-00003PubMedCrossRef
19.
go back to reference Lin H, Ma YY, Moh JS, Ou YC, Shen SY, Changchien CC: High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006, 101: 40-45. 10.1016/j.ygyno.2005.09.028PubMedCrossRef Lin H, Ma YY, Moh JS, Ou YC, Shen SY, Changchien CC: High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan. Gynecol Oncol 2006, 101: 40-45. 10.1016/j.ygyno.2005.09.028PubMedCrossRef
20.
go back to reference Harper DM: Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the phase II and III trials. Therapy 2008, 5: 313-324. 10.2217/14750708.5.3.313CrossRef Harper DM: Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the phase II and III trials. Therapy 2008, 5: 313-324. 10.2217/14750708.5.3.313CrossRef
Metadata
Title
Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development
Authors
Jee Eun Rhee
Mi Yeong Shin
Choong Mo Kim
Hye Young Kee
Jae Keun Chung
Sang-Kee Min
Seong-Joon Kim
Dai-Ho Jang
Sung Soon Kim
Byeong-Sun Choi
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-201

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue